New lower extremity revascularization CPT codes include physician payment for intravascular lithotripsy

This advertorial is sponsored by Shockwave Medical. A major overhaul of current procedural terminology (CPT) coding for lower extremity revascularization (LER) took effect in January, introducing new codes and allowing physicians to receive dedicated work relative value unit (wRVU) credit for the use of intravascular…
CIRSE begins CALCIO trial enrolment for treatment of CLTI with Shockwave IVL system

The Cardiovascular and Interventional Society of Europe (CIRSE) have announced that patient enrolment for the CALCIO trial has begun. CALCIO started patient enrolment on 15 July, 2024, with the goal of recruiting 400 chronic limb-threatening ischaemia (CLTI) patients over the…
Johnson & Johnson to acquire Shockwave Medical

Johnson & Johnson is to acquire Shockwave Medical, it has been announced today. Under the terms of the transaction, Johnson & Johnson will acquire all outstanding shares of Shockwave for US$335.00 per share in cash, corresponding to an enterprise value…
Shockwave L6 catheter expands treatment options for large-vessel cases

Shockwave IVL maintains ‘superiority’ to angioplasty in calcified peripheral disease at two years

Shockwave Medical announced today that long-term data from the Disrupt PAD III trial found that superior vessel preparation with intravascular lithotripsy (IVL) led to excellent long-term outcomes out to two years with preservation of future treatment options compared to percutaneous transluminal angioplasty (PTA)…

